Blog
    Peptide SpotlightFor PatientsApril 9, 2026

    LL-37 peptide: How this natural cathelicidin works

    Learn about LL-37, a human cathelicidin that fights bacteria, viruses, and fungi. Understand its role in wound healing and current FDA safety concerns.

    What exactly is this LL-37 thing?

    Think of LL-37 as your body's personal, built-in security guard. It is a peptide, which is just a fancy way of saying it is a small piece of a protein. Specifically, it is a 37-amino acid human cathelicidin.

    If that sounds like a mouthful, here is the short version: it is the only cathelicidin—a type of germ-fighting molecule—found in humans. This makes it an endogenous peptide, which means your body naturally manufactures it on its own.

    How does it work (and what does it fight)?

    Scientists like to call LL-37 a broad-spectrum antimicrobial. In plain English, that means it is a general-purpose fighter that goes after a huge range of invaders.

    According to the research, it takes on:

    • Bacteria (the bad germs)
    • Viruses (the tiny pests that make you sick)
    • Fungi (the stuff you definitely don't want growing on you)

    It also gets involved with Toll-like receptor signaling, which is just the body's complicated way of sending out a chemical alarm system. Plus, it helps with wound healing by encouraging keratinocytes—your skin cells—to move to where they are needed most.

    Why aren't we all using it yet?

    While your body is great at making LL-37, trying to turn it into a medicine you can take is a different story. Right now, it has a Grade C evidence rating.

    Scientists are still working on this one—turns out the human body is complicated. Who knew? While the natural version inside you is well-studied, giving people an extra dose of LL-37 (what experts call exogenous administration) hasn't really been tested in clinical trials yet.

    There are two big hurdles for the people in white lab coats:

    • Pharmaceutical challenges: It is hard to keep the peptide stable and actually get it into the body correctly.
    • Regulatory status: It is not currently approved as a therapeutic medicine.

    What do the regulators say?

    The FDA has not approved LL-37. In fact, back in September 2023, it was put into a Group called Category 2 because of safety concerns. There was even a warning letter issued regarding its use back in 2020.

    This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.


    This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.

    Referenced Peptides

    This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.